Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention. [electronic resource]
Producer: 20071017Description: 144-8 p. digitalISSN:- 1108-7161
- Administration, Oral
- Aged
- Alendronate -- administration & dosage
- Arthralgia -- chemically induced
- Back Pain -- chemically induced
- Bone Density Conservation Agents -- administration & dosage
- Cohort Studies
- Drug Administration Schedule
- Etidronic Acid -- administration & dosage
- Female
- Hemiterpenes -- metabolism
- Humans
- Injections, Intravenous -- adverse effects
- Lymphocyte Activation -- drug effects
- Male
- Mevalonic Acid -- metabolism
- Middle Aged
- Musculoskeletal Diseases -- chemically induced
- Organophosphorus Compounds -- metabolism
- Osteoporosis -- drug therapy
- Pain -- chemically induced
- Retrospective Studies
- Risedronic Acid
- T-Lymphocytes -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.